$GILD News Cypress,

New Post Public Reply Private Reply Replies (0) Message Board

Dec 8, 2014 at 12:19 PM

$GILD News

Cypress, Spansion shares rally on merger plan
5:36 p.m. Dec. 1, 2014
- MarketWatch

Mylan to manufacture, distribute Gilead Sciences HIV drug
7:49 a.m. Dec. 1, 2014
- Angela Chen

10 stocks that may revisit their highs as the year ends
10:30 a.m. Nov. 24, 2014
- Philip van Doorn

Are consumers getting gouged on health care?
9:35 a.m. Nov. 22, 2014
- Russ Britt

Gilead Sciences shares slide 1.7%
9:35 a.m. Nov. 19, 2014
- Sue Chang

The double-edged sword of growth-stock speculation
2:29 p.m. Nov. 14, 2014
- The Trading Deck

10 S&P 500 companies with the fastest revenue growth
8:28 a.m. Nov. 11, 2014
- Philip van Doorn

Merck, Dendreon miss out on health-care rally
12:39 p.m. Nov. 10, 2014
- Russ Britt

Gilead Sciences rises 2% to top S&P 500 gainers
9:31 a.m. Nov. 10, 2014
- Sue Chang

Visa shares rise after hours on earnings beat
6:50 p.m. Oct. 29, 2014
- Sue Chang

Warren Buffett best wear his trunks as Fed preps to end (pause) the printing
8:34 a.m. Oct. 29, 2014
- Shawn Langlois

Facebook, Gilead shares fall after hours
6:14 p.m. Oct. 28, 2014
- Sue Chang

Updates, advisories and surprises
5:01 p.m. Oct. 28, 2014
- MarketWatch

Sales of Gilead's pricey hepatitis C drug slow
4:26 p.m. Oct. 28, 2014
- MarketWatch.com

Gilead Sciences' stock pulls back from record high close after earnings miss
4:14 p.m. Oct. 28, 2014
- Tomi Kilgore

Gilead's stock drops 3.6% in after-hours trade after Q3 results
4:09 p.m. Oct. 28, 2014
- Tomi Kilgore

Gilead revises 2014 product sales outlook to $22 bln-$23 bln from $21 bln-$23 bln
4:08 p.m. Oct. 28, 2014
- Tomi Kilgore

Gilead Q3 Sovaldi sales $2.8 bln vs. $3.48 bln in Q2
4:07 p.m. Oct. 28, 2014
- Tomi Kilgore

Gilead Q3 sales top FactSet consensus estimate of $5.99 bln
4:07 p.m. Oct. 28, 2014
- Tomi Kilgore

Gilead Q3 sales $6.04 bln vs. $2.78 bln a year ago
4:07 p.m. Oct. 28, 2014
- Tomi Kilgore

Drug Stocks Rally But Falling Crude and Energy Stocks Weigh on S&P 500

40 min ago11:39 a.m. Dec. 8, 2014
- TheStreet.com

Stocks Near Flatline as Rally in Pharmaceuticals Overshadows Energy Selloff

11:04 a.m. Today11:04 a.m. Dec. 8, 2014
- TheStreet.com

2 Core Holdings That Belong In Every Biotech Portfolio

9:45 a.m. Today9:45 a.m. Dec. 8, 2014
- Seeking Alpha

A Comprehensive Comparison Of Gilead's Harvoni And AbbVie's Triple HCV Regimen: What The HCV Marketplace May Look Like In 2015 And Beyond

9:23 a.m. Today9:23 a.m. Dec. 8, 2014
- Seeking Alpha

Cramer's Mad Money - Ulta Salon Is Looking Good (12/5/14)

5:43 a.m. Today5:43 a.m. Dec. 8, 2014
- Seeking Alpha

Best Janus Funds to Buy for 2015

12:01 a.m. Today12:01 a.m. Dec. 8, 2014
- InvestorPlace.com

Health and Tech Funds Step Up

11:06 p.m. Dec. 7, 2014
- The Wall Street Journal Interactive Edition

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

8:22 p.m. Dec. 5, 2014
- TheStreet.com

Why Gilead Is A Better Buy Than AbbVie

2:52 p.m. Dec. 5, 2014
- Seeking Alpha

Cramer Says It May Finally Be Time to Buy Laggard Gilead Sciences

12:18 p.m. Dec. 5, 2014
- TheStreet.com

Gilead Sciences Spikes Higher As Barron's Suggests Looking Beyond Hepatitis-C

9:50 a.m. Dec. 5, 2014
- benzinga.com

'Mad Money' Lightning Round: Buy, Buy, Buy Texas Instruments

6:00 a.m. Dec. 5, 2014
- TheStreet.com

Cramer's Lightning Round - Constellation Brands Has Real Magic (12/4/14)

4:36 a.m. Dec. 5, 2014
- Seeking Alpha

Jim Cramer's 'Mad Money' Recap: Google Is Better Than the Market Thinks

8:31 p.m. Dec. 4, 2014
- TheStreet.com

Hot Drugmakers Build More Labs, Grab Space In Boston

3:47 p.m. Dec. 4, 2014
- Investors Business Daily

Gilead Sciences: An Alpha Stock Through The Good And Bad Times

3:14 p.m. Dec. 4, 2014
- Seeking Alpha

A Practical Approach To Tech Investing

9:00 a.m. Dec. 4, 2014
- Seeking Alpha

U.S. Veterans get Sovaldi for $594/pill

8:43 a.m. Dec. 4, 2014
- Seeking Alpha

Cramer's Mad Money - PVH Fits Well At A Discount (12/3/14)

6:04 a.m. Dec. 4, 2014
- Seeking Alpha

Jim Cramer's 'Mad Money' Recap: Cyclical Stocks Are Fund Manager Picks Now

8:36 p.m. Dec. 3, 2014
- TheStreet.com

Gilead Presents Follow-up Data from Zydelig Registrational Studies in
Patients with Chronic Lymphocytic Leukemia, Follicular Lymphoma and
Small Lymphocytic Lymphoma
10:00 a.m. Today10:00 a.m. Dec. 8, 2014
- BusinessWire - BZX

Reveal Earnings Forecast for Gilead Sciences, Apple, Transocean, Halliburton, Ctrip, and Sirius XM
8:45 a.m. Today8:45 a.m. Dec. 8, 2014
- PR Newswire - PRF

Reveal Earnings Forecast for Gilead Sciences, Kinder Morgan, JD.Com, Sirius XM, Apple, and Plug Power
8:45 a.m. Dec. 4, 2014
- PR Newswire - PRF

Earnings Forecast Reports for Apple, Alibaba, Kinder Morgan, Gilead Sciences, Plug Power, and Yahoo
8:45 a.m. Dec. 2, 2014
- PR Newswire - PRF

Mylan Signs Agreement with Gilead to Enhance Access to Tenofovir Alafenamide (TAF)-based HIV Treatments in Developing Countries
7:00 a.m. Dec. 1, 2014
- PR Newswire - PRF

Reveal Earnings Forecast for Apple, Alibaba, Hewlett-Packard, Gilead Sciences, Petrobras, and BlackBerry
8:45 a.m. Nov. 26, 2014
- PR Newswire - PRF

Critical Alerts For SouFun, Petroleo Brasileiro, Gilead Sciences, Transocean and iRobot Released By InvestorsObserver
9:31 a.m. Nov. 24, 2014
- PR Newswire - PRF

Earnings Forecast Research for Kinder Morgan, Petrobras, Freeport-McMoRan, Keurig Green Mountain, Gilead Sciences, and Alibaba
8:45 a.m. Nov. 24, 2014
- PR Newswire - PRF

Earnings Forecast Report for Yahoo, Alibaba, Cliffs Natural Resources, Gilead Sciences, Apple, and Plug Power
8:45 a.m. Nov. 20, 2014
- PR Newswire - PRF

Knight Sells Priority Review Voucher to Gilead
5:11 p.m. Nov. 19, 2014
- Marketwired

European Commission Grants Marketing Authorization for Gilead’s
Harvoni®▼ (Ledipasvir/Sofosbuvir), the First
Single Tablet Regimen to Treat the Majority of Chronic Hepatitis C
Patients With Genotype 1 and 4
10:07 a.m. Nov. 18, 2014
- BusinessWire - BZX

Earnings Forecast Buzz for Baker Hughes, Halliburton, Apple, Gilead Sciences, Kinder Morgan, and Alibaba
8:45 a.m. Nov. 18, 2014
- PR Newswire - PRF

Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene
9:10 a.m. Nov. 14, 2014
- PR Newswire - PRF

Reveal Earnings Forecast for BlackBerry, Twitter, Alibaba, Sirius XM, Gilead Sciences, and JD.Com
8:45 a.m. Nov. 14, 2014
- PR Newswire - PRF

Gilead Prices $4 Billion of Senior Unsecured Notes
5:59 p.m. Nov. 12, 2014
- BusinessWire - BZX

Earnings Forecast Recap for Alibaba, Apple, Zynga, Gilead Sciences, Dendreon, and Juniper
8:45 a.m. Nov. 12, 2014
- PR Newswire - PRF

Gilead Announces Phase 2 Data for Investigational All-Oral Regimen of
Sofosbuvir Plus GS-5816 for the Treatment of Chronic Hepatitis C
8:02 a.m. Nov. 11, 2014
- BusinessWire - BZX

Gilead Announces Harvoni Study Results in Chronic Hepatitis C
Patients with Advanced Liver Disease and Those Who Failed Prior Treatment
8:02 a.m. Nov. 11, 2014
- BusinessWire - BZX

Earnings Forecast Buzz for Alibaba, Genworth Financial, Gilead Sciences, Zynga, Abercrombie & Fitch, and Plug Power
8:45 a.m. Nov. 10, 2014
- PR Newswire - PRF

Medifocus to Be Broadcast on BNN and Fox Business News on November
8th and 9th, 2014
10:56 a.m. Nov. 7, 2014
- Marketwired

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intellectia.AI Transforming Trading with AI Upgrades

Intellectia.AI Sparks New Trading Era Intellectia.AI, from the bustling streets of New York, is cutting through the noise with a flashy update to its AI-powered trading setup. They've thrown a heap of new toys into the ring, letting folks piggyback on high-grade stock moves in the blink of an eye. Gone are the days of fumbling with cumbersome data and execution. Breaking...

Sony Expands Versatile Wireless Headphone Lineup: 2026

Renewed Focus on Sound: Sony's Latest Headphones Sony's dipping into the headphone market this time with a splash of style and sound signature updates. We've got the WH-1000XM4C, a next-gen version of the top-dog noise-cancelling cans, that are gonna catch the eye of every audiophile and traveler out there. WH-1000XM4C: The Flagship gets a Lift What they're offering is...

1M+ California Homes Face Extreme Wildfire Risk Revealed

Wildfire Risk in California: A Growing Alarm If there's one thing that's become a bitter truth over the years, it's that California and wildfires are inseparably linked, like mayo on a greasy diner BLT—except way worse for the gut. The latest round of data from Guidewire HazardHub is practically sounding the alarm bells louder than ever. Over a million homes in...

Supernova SPAC Lawsuit: Settlement Proposed, $3M on Table

Legal Clouds Over Supernova's SPAC Adventure Alright, folks, buckle up, because whenever you mix SPACs and lawsuits, you're in for a roller coaster. Supernova Partners Acquisition Company, Inc. stands right at the heart of a class action lawsuit, and it's been cooking ever since the court in Delaware gave it a nudge forward. Settlement Talk: What's on the Table? So here's...

SKF's Automotive Arm Set for Stockholm Debut in Dec

The Big Spin-Off Play: SKF Vertevo So, SKF is at it again, pushing their Automotive business out the door as a newly minted public company—SKF Vertevo—on the horizon. It's like watching a mother bird kick the fledgling out of the nest. The Board's cooked up this spin-off strategy, and they're eyeing the Nasdaq Stockholm as the breeding ground, with the gears all set...

MADD, Uber Rally at Capital Invitational for Safe Choices

Driving Change at the Capital Invitational Let's talk about a powerhouse collaboration aiming to do more than just thrill basketball fans. We're looking at MADD Sports, Uber, and the Capital Invitational joining forces at The St. James in Springfield, Virginia, on December 10, 2026. This is not your average sporting event; it's a gathering with a bigger purpose. The...

Lyon Biennale 2026: Art, Dreams, and Lyon's Magic

Unveiling the Art Spectacle in Lyon Alright, buckle up folks, because the 18th Lyon Biennale – Contemporary Art is about to take the stage in grand fashion. Starting on the 19th of September, this art fiesta is not just any exhibit; it's an eleven-venue citywide takeover that runs until the 13th of December, and it is poised to shake up the art scene like a good splash...

ASCEND® Cladding Unveils New Profiles & Texture Variety

New Options for Creative Home Exteriors Amid today's housing market rollercoaster, a sprinkle of bold innovation in building materials can make a statement—and that's precisely what Associated Materials Innovations (AMI) is banking on with their latest beef-up in the ASCEND® Composite Cladding lineup. Introduced out of Cuyahoga Falls on Sept. 8, 2026, this expansion...

AB SKF to Hold EGM, Spin Off Automotive Assets

SKF's Extraordinary Meeting: A Pivotal Moment AB SKF, a heavyweight in the industrial technology sector, is summoning its shareholders for an Extraordinary General Meeting on October 1, 2026. The venue? The Elite Park Avenue Hotel in Gothenburg, Sweden—sounds fancy, but don't expect to hear a string quartet at this shindig. What's truly on the agenda is a critical...

PBC 2026 Forum: Philanthropic Titans Collide in HK

A Decade of Philanthropic Discourse The winds of change blew through Hong Kong’s West Kowloon Cultural District today, marking the tenth anniversary of the PBC 2026 forum—an event that’s got everyone from government bigwigs to sports icons chatting. Convened by The Hong Kong Jockey Club Charities Trust alongside the Institute of Philanthropy, this two-day journey is...